Published by Coherent Market Insights
Posted on September 17, 2021
Digital Breast Tomosynthesis (DBT) Equipment is a product advanced through a crew of breast augmentation medical doctors and technicians, with an purpose to offer sufferers with one of the maximum reliable, safest, and cost-powerful tactics to be had. As this innovative new breast enhancement process isn’t always to be had in each area, it is able to be tough to discover the best device to fit your precise needs. Digital breast tomosynthesis device is designed to offer all-over development to the breasts in order that any female can get the appearance she needs with out incurring outrageous costs. DBT additionally called 3-D mammography, is likewise utilized by radiologists to diagnose breast cancer. It makes use of a chain of two-dimensional pictures to construct a 3-D photo of the breast.
Request for a Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/3445
Increasing prevalence of breast cancer is expected to drive growth of the global digital breast tomosynthesis equipment market during the forecast period. According to the World Cancer Research Fund, in 2018, there were over 2 million new cases of breast cancer across 25 countries in the world. According to the American Cancer Society, in 2020, around 276,480 new cases of invasive breast cancer are expected to be diagnosed in the U.S. in women with over 40,000 women dying from it. Such a massive prevalence of breast cancer has increased the demand for DBT equipment across the globe. Thus, these factors are expected to drive growth of the global digital breast tomosynthesis equipment market during the forecast period. Furthermore, rising awareness regarding the use of DBT equipment as well as technological advancements in the field of breast imaging is expected to propel the global digital breast tomosynthesis equipment market growth in the near future.
However, the high capital cost of the equipment combined with side-effects related to radiation exposure is expected to restrict growth of the global digital breast tomosynthesis equipment market during the forecast period. Furthermore, among regions, North America is expected to witness significant growth in the global digital breast tomosynthesis equipment market during the forecast period. This is owing to high demand for innovative products as well as the presence of skilled healthcare professionals in the region.
Key players involved in the global digital breast tomosynthesis equipment market are Hologic, Inc., Trivitron Healthcare, GE Healthcare, Analogic Corporation, Fujifilm Holdings Corporation, Planmed Oy, Siemens Healthineers, and General Medical Merate SpA.
For instance, in March 2020, Hologic Inc., a U.S.-based medical technology company, received the U.S. Food and Drug Administration (FDA) approval for its 3DQuorum Imaging Technology, which is powered by Genius AI.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/3445
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post [2021] Digital Breast Tomosynthesis Equipment Market Share Is Anticipated to touch US$ 4,212.4 Million By 2027 appeared first on Gatorledger.
Digital Breast Tomosynthesis (DBT) Equipment is a product advanced through a crew of breast augmentation medical doctors and technicians, with an purpose to offer sufferers with one of the maximum reliable, safest, and cost-powerful tactics to be had. As this innovative new breast enhancement process isn’t always to be had in each area, it is able to be tough to discover the best device to fit your precise needs. Digital breast tomosynthesis device is designed to offer all-over development to the breasts in order that any female can get the appearance she needs with out incurring outrageous costs. DBT additionally called 3-D mammography, is likewise utilized by radiologists to diagnose breast cancer. It makes use of a chain of two-dimensional pictures to construct a 3-D photo of the breast.
Request for a Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/3445
Increasing prevalence of breast cancer is expected to drive growth of the global digital breast tomosynthesis equipment market during the forecast period. According to the World Cancer Research Fund, in 2018, there were over 2 million new cases of breast cancer across 25 countries in the world. According to the American Cancer Society, in 2020, around 276,480 new cases of invasive breast cancer are expected to be diagnosed in the U.S. in women with over 40,000 women dying from it. Such a massive prevalence of breast cancer has increased the demand for DBT equipment across the globe. Thus, these factors are expected to drive growth of the global digital breast tomosynthesis equipment market during the forecast period. Furthermore, rising awareness regarding the use of DBT equipment as well as technological advancements in the field of breast imaging is expected to propel the global digital breast tomosynthesis equipment market growth in the near future.
However, the high capital cost of the equipment combined with side-effects related to radiation exposure is expected to restrict growth of the global digital breast tomosynthesis equipment market during the forecast period. Furthermore, among regions, North America is expected to witness significant growth in the global digital breast tomosynthesis equipment market during the forecast period. This is owing to high demand for innovative products as well as the presence of skilled healthcare professionals in the region.
Key players involved in the global digital breast tomosynthesis equipment market are Hologic, Inc., Trivitron Healthcare, GE Healthcare, Analogic Corporation, Fujifilm Holdings Corporation, Planmed Oy, Siemens Healthineers, and General Medical Merate SpA.
For instance, in March 2020, Hologic Inc., a U.S.-based medical technology company, received the U.S. Food and Drug Administration (FDA) approval for its 3DQuorum Imaging Technology, which is powered by Genius AI.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/3445
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post [2021] Digital Breast Tomosynthesis Equipment Market Share Is Anticipated to touch US$ 4,212.4 Million By 2027 appeared first on Gatorledger.
Explore more articles in the Research Reports category
